admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Revive Therapeutics Provides Update From Type C Meeting with FDA for...

BetterLife Announces Offering of Units

PT396 – Moms on Mushrooms: Motherhood and Psychedelics Inside a Broken...

Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders...

Mind the Gap: The Importance of Gender Equity in Psychedelic Clinical...

Inside Synthesis Institute’s Implosion

Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference

Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial...

Numinus Wellness Inc. Executives to Present on Panel at Upcoming South...

atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates

1...808182...218 Page 81 of 218

EDITOR PICKS

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin